Department of Medical Affairs & Pharmacovigilance • Clinical Formulary Monograph
D 92/6 Okhla Phase 1, New Delhi, 110020, India • Medical Helpline: +91 11-47532297 • Email: contact@vrmedhealthcare.com
Vibanuron
Pregabalin with Methylcobalamin Neuropathic Pain Formulation
Vibanuron
Pregabalin with Methylcobalamin Neuropathic Pain Formulation
Pregabalin IP 75mg + Methylcobalamin IP 750mcg
Product Clinical Overview
Vibanuron combines Pregabalin, an alpha-2-delta calcium channel ligand, with Methylcobalamin, the active coenzyme form of vitamin B12. The combination addresses neuropathic pain symptomatically while supporting peripheral nerve repair and myelination.
More Images
Actual Vibanuron packaging, label panels and blister strip.
Key Ingredients & Pharmacological Profiles
Active chemical constituents, standardized strengths, and physiological roles.
α2δ ligand reducing excitatory neurotransmitter release in hyperexcited neurons.
Active vitamin B12 supporting axonal regeneration and myelin synthesis.
Approved Clinical Indications
Clinical contexts where this formulation is prescribed under medical supervision.
Pharmacological Mechanism of Action
Pregabalin binds the α2δ subunit of voltage-gated calcium channels, reducing release of glutamate, noradrenaline and substance P. Methylcobalamin participates in methylation reactions essential for myelin lipid synthesis and promotes neuronal regeneration.
Formulation & Delivery Technology
- Symptom relief combined with neuro-regenerative support
- Active methyl form of B12 needs no hepatic conversion
- Schedule H prescription formulation
VR Med Healthcare Pvt. Ltd.
Registered Office & Facility:D 92/6 Okhla Phase 1, New Delhi, 110020, India
Quality Certifications:WHO-GMP Compliant & ISO 9001:2015 Certified
Medical Helpline:+91 11-47532297
Corporate Email:contact@vrmedhealthcare.com
Administration & Packaging Details
As directed by the Physician.
10 x 10 Tablets (Blister Strip)
Store in a cool, dry and dark place. Protect from light and moisture.
This formulation monograph is published strictly for the professional scientific reference and educational use of Registered Medical Practitioners, Hospitals, and Clinical Laboratories. The technical and pharmacological details presented herein do not constitute medical advice, diagnostic opinion, or therapeutic claims. These products must be prescribed, dispensed, and administered strictly in accordance with local drug regulations and under the supervision of a licensed physician. VR Med Healthcare Pvt. Ltd. does not promote self-medication, off-label usage, or unsolicited consumer health claims.
More in Pain & Muscle
Etoversa-MR
Targeted COX-2 Inhibitor & Spasmolytic Muscle Relaxant
Etoversa-60
Selective COX-2 Inhibitor for Joint & Musculoskeletal Pain
Tremasine
Centrally Acting Opioid & Analgesic-Antipyretic Combination
Enhancing Lives With
Quality Healthcare & Integrity.
VR Med Healthcare has been a trusted benchmark in the Indian pharmaceutical sector since 2010. Headquartered in Okhla Phase 1, New Delhi, our dedicated team of over 100 professionals collaborates with leading physicians and distributors across India to make premium medicines accessible and reliable.
“Our goal is to deliver quality of care in a courteous, respectful, and compassionate manner. We hope you will allow us to care for you and strive to be the first and best choice for healthcare professionals and families.”
Kamal Choudhary
Managing Director, VR Med Healthcare
Established
Approved Formulations
Healthcare Specialists
Manufacturing Standard